 
[ADDRESS_1185411] Sc iences Protocol 2018 -10: “An Evaluation of a Mu lti-
Target Stool DNA (mt -sDNA ) Test, Colog uard , For CRC Screening in Indivi duals Aged 45 -49 and 
at Aver age Risk for Development of Colorectal Cancer: Act Now ” 
 
NCT Number : [STUDY_ID_REMOVED]  
 
Document D ate: October 16th, [ADDRESS_1185412] 
SCIENCES PROTOCOL 2018 -10: “ AN 
EVALUATION OF A MULTI -TARGET STOOL DNA 
(mt-sDNA) TEST, COLOGUARD, FOR CRC 
SCREENING IN INDIVIDUALS AGED 45 -49 AND AT 
AVERAGE RISK FOR DEVELOPMENT OF 
COLORECTAL CANCER: ACT NOW ”  
 
 
 
Study Title:  Blood Collection Sub- Study of Exact Sciences Protocol 2018- 10: “An Evaluation 
of a Multi -target Stool DNA (mt -sDNA) Test, Cologuard, for CRC Screening in 
Individuals Aged 45- 49 and at Average Risk for Development of Colorectal 
Cancer : Act Now ” 
Study Number :   2018- 10B 
Version and Date:  Protocol Synopsis Version 2.0, October 16 , 2018  
Study Sponsor :  Exact Sciences 
   [ADDRESS_1185413]  
Madison, WI [ZIP_CODE]  
    
 
 
 
 
 
 
   
 
 
2 Protocol  Synopsis 2018 -10B V 2.0 
 
1 PROTOCOL SYNOPSIS  
Primary Objective: The primary objective of this sub -study (2018 -10B) is to 
collect blood samples for research use in the 
development of the blood- based test for colorectal 
cancer  (CRC) . 
Study Design: Prospective , multi -center,  sample  collection  sub-study  
Population:  Subjects will be men and women, [ADDRESS_1185414] Sciences Protocol 2018- 10. Up to 
914 subjects will be enrolled.  
Study Duration:  Duration of subject participation in this sub -study will 
be 1 day from enrollment to completion.  
Study Procedures: Subjects  providing written informed consent to 
participate in the sub- study will have blood draw n. 
[ADDRESS_1185415] meet the following criteria to be eligible for the study:  
1. Subject is currently enrolled in Exact Sciences Protocol 2018- 10. 
2. Subject is willing and able to provide a blood sample.  
3. Subject is willing and able to sign informed consent.  
5 Exclusion Criteria  
Subjects presenting with any of the following will not be included in the study:  
1. Subject has any condition that in the opi[INVESTIGATOR_852532].  
 
 
   
 
 
3 Protocol  Synopsis 2018 -10B V 2.0 
 
APPENDIX 1 .0 – STUDY SCHE DULE  
 
Activity  Enrollment Visit  
Informed Consent  X 
Obtain Blood Sample  X 
Adverse Event Reporting  X 
 
 
 
 
  
 
 
 